Loading the player… Onxeo Just Announced Acquisition of DNA Therapeutics and Provides Update on Portfolio. “Onxeo S.A. , an innovative company specializing in the development of orphan oncology therapeutics, today announced that it has reached an agreement to acquire DNA Therapeutics, a privately-held, clinical-stage biopharmaceutical company, for its signal-interfering DNA repair technology, which is directed at […]
Read moreLoading the player… Web TV www.labourseetlavie.com partner of Oddo Forum 2016 held in Lyon on 7 and 8 January met many leaders to talk about the year 2015 and 2016 outlook . Back to news biotechnology company specializing in the development of innovative protein formulations. My guest to discuss the strategy is Gérard Soula CEO […]
Read moreLa Web Tv is partner for Oddo Midcap Forum 2014 : Strategy and target for Valneva. We talk with Reinhard Kandera CFO Valneva about strategy and perpectives after the merger between Intercell and Vivalis. Is the Merger on track ?
Read more